STARD8: A Potential Drug Target and Biomarker for Multiple Chronic Diseases

Target Name: STARD8

NCBI ID: G9754

STARD8

STARD8: A Potential Drug Target and Biomarker for Multiple Chronic Diseases

Stard8, a novel gene named after its discoverer, Dr. Stephen Streltman, is a highly expressed gene in human tissues, and its function is still not entirely clear. However, research has shown that STARD8 is involved in various physiological processes, including cell signaling, DNA repair, and metabolism. In recent years, increasing evidence has suggested that STARD8 may be a drug target and biomarker for various chronic diseases, including cancer, neurodegenerative diseases, and metabolic disorders. In this article, we will explore the potential implications of STARD8 as a drug target and biomarker.

Potential Drug Target

The protein encoded by the STARD8 gene, known as STARD8, has been shown to play a role in various cellular processes that are crucial for human health. One of the key functions of STARD8 is its role in the DNA damage response pathway. This pathway is critical for ensuring that damaged DNA is repaired and that genetic errors are minimized. Mutations in the STARD8 gene have been linked to various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The DNA damage response pathway is also important for the development of drug resistance in cancer cells. cancer cells often have mutations in the DNA that result in damage to the DNA damage response pathway. These mutations can lead to the development of drug resistance, making the cancer cells more difficult to treat. Therefore, targeting STARD8 and its associated pathways may be a promising strategy for the development of new cancer therapies.

Potential Biomarker

In addition to its potential role as a drug target, STARD8 has also been suggested as a potential biomarker for various diseases. The STARD8 gene has been shown to be expressed in various tissues and cells, including brain, heart, and liver. This suggests that it may be a useful biomarker for tracking disease progression and evaluating the effectiveness of treatments.

Studies have also shown that STARD8 is involved in the regulation of cellular processes that are crucial for human health. For example, STARD8 has been shown to play a role in the regulation of cell apoptosis, which is a natural process that helps remove damaged or dysfunctional cells from the body. This suggests that STARD8 may be a useful biomarker for tracking the effectiveness of treatments that promote cell death.

Conclusion

In conclusion, STARD8 is a gene that has been shown to play a role in various physiological processes in human cells. The increasing evidence that STARD8 may be a drug target and biomarker for various chronic diseases makes it an attractive target for future research. Further studies are needed to fully understand the functions of STARD8 and its potential as a drug and biomarker.

Protein Name: StAR Related Lipid Transfer Domain Containing 8

Functions: Accelerates GTPase activity of RHOA and CDC42, but not RAC1. Stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1

The "STARD8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STARD8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets